Quantcast
Last updated on April 16, 2014 at 0:16 EDT

Latest Immunosuppressive drug Stories

2009-11-23 15:36:54

People need longer-term support than most friends, relatives or health care professionals realize People who have kidney transplants need longer-term support than most friends, relatives or even healthcare professionals realise, according to a study of 160 patients published in the December issue of the UK-based Journal of Advanced Nursing. Researchers surveyed 55 patients who had undergone surgery in the last year, together with 105 who had had surgery in the last one to three years at the...

2009-11-01 06:19:03

Treatment reduces risk, but nearly half of patients stop treatment due to side effects Switching to a newer type of immunosuppressant drug may reduce the high rate of skin cancer after kidney transplantation, according to research presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA. "In spite of the life-saving nature of organ transplantation, the need for transplant recipients to continue treatment with drugs that suppress the...

2009-10-29 14:32:48

Overall cancer risk comparable to those not taking immunosuppressive drugs A recent study by Swedish researchers found that rheumatoid arthritis (RA) patients did not experience an elevated cancer risk in the first 6 years after starting anti-tumor necrosis factor (TNF) therapy. The research team, led by Johan Askling, M.D., Ph.D., from Karolinska University Hospital in Stockholm, Sweden assessed the short-term and medium-term cancer risk for RA patients using anti-TNF therapies: infliximab,...

2009-10-26 22:53:59

Findings from a new retrospective cohort study presented at the American College of Gastroenterology's 74th Annual Scientific meeting in San Diego indicate that patients with Inflammatory Bowel Disease (IBD), especially those receiving the thiopurine class of medications to treat IBD, may be at risk for developing non-melanoma skin cancer (NMSC). Dr. Millie Long, of the University of North Carolina, Chapel Hill, and her colleagues examined the records of 26,403 patients with Crohn's disease...

2009-10-08 15:23:00

AST Delivers Letter to Senate Leadership WASHINGTON, Oct. 8 /PRNewswire-USNewswire/ -- As the Senate Finance Committee prepares to vote on the amended health care reform package, members of the American Society of Transplantation (AST) arrived on Capitol Hill armed with a letter encouraging the Senate to adopt a health care provision that will extend Medicare's coverage of post-transplant drugs, which are critical to maintaining the health of the transplant patient. Immunosuppressive...

2009-10-08 11:53:00

WASHINGTON, Oct. 8 /PRNewswire/ -- As Congress wraps up work on health care reform, members of the American Society of Transplantation's (AST) Public Policy Committee arrived on Capitol Hill today to discuss the importance of supporting a health care provision that would ensure kidney transplant recipients continue to receive Medicare coverage for immunosuppressive drugs. The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009, in the health care reform...

2009-10-05 10:56:55

Data from the largest single-center experience of adult and pediatric intestinal and multivisceral transplantation show that survival rates have improved with the advent of innovative surgical techniques, novel immunosuppressive protocols and better post-operative management, said researchers at the Thomas E. Starzl Transplantation Institute in a study published in the October issue of Annals of Surgery. Led by Kareem Abu-Elmagd, M.D., Ph.D., director, Intestinal Rehabilitation and...

2009-09-03 12:22:00

NEW YORK, Sept. 3 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Liver Disease Treatments: The Global Market http://www.reportlinker.com/p0128142/Liver-Disease-Treatments-The-Global-Market.html This Report: Provides an overview of the global market for liver disease treatments, with market forecasts through 2014 Classifies therapies based on diseases including virus-induced liver disease/Hepatitis, liver tumors, autoimmune...

2009-08-12 18:35:00

DEERFIELD, Ill., Aug. 12 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas") announced today an update regarding the status of the request for emergency relief and preliminary injunction from the U.S. Food and Drug Administration's (FDA) decision regarding its Citizen Petition. The company's requests have been denied by the U.S. District Court in Washington, D.C. The company is disappointed in the court's decision and is currently evaluating its next course of action. The Citizen...

2009-08-10 22:52:00

DEERFIELD, Ill., Aug. 10 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas") announced today that the U.S. Food and Drug Administration (FDA) has substantially denied the company's Citizen Petition to ensure the safe and effective use of immunosuppressants (also called anti-rejection medications) used to prevent rejection in organ transplant patients. In their petition, Astellas requested that the FDA take additional measures to protect transplant recipients, a unique and vulnerable...